Table of Contents
Overview
New York, NY – Sep 19, 2025 – The Global Biopreservation Market size is expected to be worth around USD 35.3 Billion by 2033 from USD 3.7 Billion in 2024, growing at a CAGR of 28.4% during the forecast period 2025 to 2033
Biopreservation has emerged as a critical technology supporting the long-term stability and functionality of biological materials. It refers to the storage of cells, tissues, organs, and other biological products under controlled conditions to ensure their viability for research, therapeutic, and diagnostic applications. The increasing demand for regenerative medicine, stem cell therapy, and organ transplantation is fueling significant investments in biopreservation solutions.
The growth of the market is being driven by the rising adoption of advanced preservation methods such as cryopreservation and vitrification, along with the expanding use of biobanking facilities worldwide. In addition, the increasing prevalence of chronic diseases and the growing focus on personalized medicine are accelerating the need for safe and effective preservation of biological samples.
Technological innovations in equipment, such as ultra-low temperature freezers, liquid nitrogen systems, and integrated monitoring devices, are strengthening the reliability of biopreservation practices. Furthermore, favorable government initiatives and strategic collaborations among pharmaceutical companies, research institutes, and healthcare organizations are expanding the scope of application.
North America currently represents the leading market, supported by a robust research infrastructure and significant healthcare investments. However, rapid growth is being observed across Asia-Pacific due to rising healthcare expenditure and an increasing number of biobanks. The biopreservation market is poised for sustained expansion, as it plays a pivotal role in advancing medical research, supporting life sciences innovation, and enhancing global healthcare outcomes.
Key Takeaways
- Market Size: The global biopreservation market was valued at USD 2.9 billion in 2023 and is projected to reach approximately USD 35.3 billion by 2033.
- Market Growth: The market is anticipated to expand at a robust compound annual growth rate (CAGR) of 28.4% during the forecast period 2024–2033.
- Product Analysis: In 2023, the equipment segment accounted for the largest share of the market, representing 44.4% of total revenue.
- Application Analysis: Biobanking emerged as the leading application area in 2023, capturing a significant share of 50.0%.
- Cell Provider Analysis: The tumor cells segment demonstrated remarkable performance, contributing 38.5% of revenue in 2023.
- Regional Analysis: North America maintained market leadership, holding the highest revenue share of 42.2% in 2023.
- Regulatory Impact: The market is influenced by stringent regulations governing the storage, handling, and transportation of biological samples, shaping compliance strategies and operational frameworks.
- Research and Development: Increased research investments by biopharmaceutical companies are driving demand for biopreservation, particularly for long-term biological sample storage and advanced therapeutic applications.
Regional Analysis
North America Leading the Biopreservation Market
North America accounted for the largest share of the biopreservation market in 2023, representing 42.2% of global revenue. The region’s dominance is attributed to advancements in biobanking, regenerative medicine, and personalized medicine. Rising demand for organ transplants, cell therapies, and vaccines has accelerated the adoption of advanced preservation technologies, including cryopreservation and hypothermic storage.
Major market participants are actively investing to strengthen innovation and expand their offerings. For example, in November 2023, BioLife Solutions secured USD 10.4 million through a private placement led by Casdin Capital. The investment was directed toward enhancing the company’s biopreservation media and associated solutions, enabling it to scale operations and meet the increasing demand across the healthcare sector. Furthermore, the strong presence of biotechnology and pharmaceutical research activities continues to reinforce the region’s market growth.
Asia Pacific Expected to Witness the Fastest Growth
The Asia Pacific biopreservation market is projected to record the highest CAGR during the forecast period. The rapid expansion is driven by rising investments in biopharmaceutical infrastructure and the growing demand for cell therapies. China, Japan, and South Korea are anticipated to play leading roles in regional growth, supported by large-scale investments in life sciences.
In 2024, Merck announced an investment exceeding USD 321.7 million in a new Bioprocessing Production Center in Daejeon, South Korea—the largest investment by Merck’s Life Science business sector in the Asia Pacific region. The facility is expected to advance bioprocessing technologies and generate around 300 new jobs by 2028. This development, along with the region’s increasing emphasis on regenerative medicine and biobanking, is set to significantly accelerate market expansion.
Frequently Asked Questions On Biopreservation
- What is biopreservation?
Biopreservation refers to the process of preserving biological materials such as cells, tissues, organs, and biofluids under controlled conditions. This method maintains their integrity, viability, and functionality for extended periods, supporting clinical, research, and industrial applications. - Why is biopreservation important in healthcare?
Biopreservation plays a critical role in healthcare by ensuring the long-term storage of cells and tissues for transplantation, regenerative therapies, vaccines, and research. It helps maintain biological samples without compromising their quality or therapeutic effectiveness. - What techniques are commonly used in biopreservation?
The most common techniques include cryopreservation, lyophilization, and vitrification. These approaches use controlled freezing or drying methods combined with cryoprotectants to prevent cellular damage, thereby enabling biological samples to remain viable for future use. - What are cryoprotective agents (CPAs) in biopreservation?
Cryoprotective agents are chemical substances used to protect biological materials during freezing or thawing. They reduce ice crystal formation and cellular stress, thus improving survival rates of cells and tissues during long-term storage processes. - What is the biopreservation market?
The biopreservation market refers to the industry that provides products, equipment, reagents, and services supporting the storage and preservation of biological samples. It includes cryopreservation systems, biobanks, consumables, and preservation media used in clinical and research settings. - What factors are driving the growth of the biopreservation market?
Market growth is driven by the rising demand for regenerative medicine, increasing biobanking activities, advancements in stem cell research, and the need for effective preservation methods supporting personalized medicine and biologics development. - Which regions dominate the biopreservation market?
North America currently dominates due to strong research infrastructure, high adoption of advanced technologies, and established biobanking facilities. Europe and Asia-Pacific are also experiencing significant growth due to government support and expanding biotechnology industries. - Who are the key end-users of biopreservation products?
Key end-users include hospitals, research laboratories, biopharmaceutical companies, and biobanks. These institutions rely heavily on preservation technologies for clinical storage, drug discovery, regenerative therapies, and personalized medicine research, driving consistent demand within the market.
Conclusion
The biopreservation market is experiencing rapid expansion, supported by advancements in preservation technologies, rising demand for regenerative medicine, and growing biobanking activities. With a projected CAGR of 28.4% from 2024 to 2033, the market demonstrates strong growth potential across applications such as organ transplantation, cell therapy, and personalized medicine.
North America remains the largest market, while Asia-Pacific is set to witness the fastest growth due to increasing investments in life sciences infrastructure. Favorable government initiatives, strategic collaborations, and technological innovations are expected to further strengthen the industry, positioning biopreservation as a cornerstone of modern healthcare and biomedical research.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
